We are live on
!
Find out more
DMKJ
David M. Knott Jr Portfolio holdings
AUM
$168M
1-Year Est. Return
60.36%
This Fund
S&P 500
This Quarter
Est. Return
-2.49%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$168M
AUM Growth
-$47.9M
(-22%)
Cap. Flow
-$34.3M
Cap. Flow
% of AUM
-20.4%
Top 10 Holdings %
Top 10 Hldgs %
60.49%
Holding
95
New
8
Increased
17
Reduced
13
Closed
10
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
+$5.12M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$2.13M |
| 3 |
Relmada Therapeutics
RLMD
|
+$2.08M |
| 4 |
Ardelyx
ARDX
|
+$1.37M |
| 5 |
TG Therapeutics
TGTX
|
+$1.34M |
Top Sells
| 1 |
Calumet Specialty Products
CLMT
|
+$44M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
+$1.64M |
| 3 |
TECX
Tectonic Therapeutic
TECX
|
+$1.54M |
| 4 |
Travere Therapeutics
TVTX
|
+$1.36M |
| 5 |
Biohaven
BHVN
|
+$1.25M |
Sector Composition
| 1 | Healthcare | 53.57% |
| 2 | Financials | 19.49% |
| 3 | Communication Services | 15.66% |
| 4 | Technology | 1.31% |
| 5 | Energy | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.5T
| $26.2M | 15.61% |
91,420
| – | – |
|
2
Apollo Global Management
APO
$68.9B
| $25.1M | 14.92% |
225,000
| – | – |
|
3
Syndax Pharmaceuticals
SNDX
$2.08B
| $9.86M | 5.87% |
422,000
+7,000
| +2% | +$152K |
|
4
BridgeBio Pharma
BBIO
$16B
| $6.68M | 3.98% |
90,000
+5,000
| +6% | +$362K |
|
5
Protagonist Therapeutics
PTGX
$8.65B
| $6.64M | 3.95% |
63,000
-10,000
| -14% | -$885K |
|
6
Xeris Biopharma Holdings
XERS
$1.5B
| $6.15M | 3.66% |
1,060,000
+90,000
| +9% | +$597K |
|
7
JPMorgan Chase
JPM
$912B
| $5.73M | 3.41% |
19,477
| – | – |
|
|
8
Iovance Biotherapeutics
IOVA
$2.13B
| $5.62M | 3.34% |
+1,600,000
| New | +$5.12M |
|
9
Janus Henderson AAA CLO ETF
JAAA
$29B
| $4.71M | 2.8% |
93,528
| – | – |
|
10
Alkermes
ALKS
$8.63B
| $4.24M | 2.53% |
120,000
+25,000
| +26% | +$776K |
|
|
11
Travere Therapeutics
TVTX
$5.2B
| $4.18M | 2.49% |
140,633
-45,367
| -24% | -$1.36M |
|
12
Cogent Biosciences
COGT
$6.69B
| $4M | 2.38% |
104,000
+2,000
| +2% | +$73.9K |
|
13
Viridian Therapeutics
VRDN
$2.08B
| $3.54M | 2.11% |
181,000
+36,000
| +25% | +$1.07M |
|
|
14
Agios Pharmaceuticals
AGIO
$2.35B
| $3.15M | 1.87% |
93,058
+75,058
| +417% | +$2.13M |
|
|
15
Relmada Therapeutics
RLMD
$648M
| $3.06M | 1.82% |
+439,300
| New | +$2.08M |
|
|
16
TG Therapeutics
TGTX
$8.58B
| $2.99M | 1.78% |
90,001
+45,001
| +100% | +$1.34M |
|
|
17
Catalyst Pharmaceutical
CPRX
| $2.97M | 1.77% |
120,000
-69,000
| -37% | -$1.64M |
|
|
ACLX
18
DELISTED
Arcellx
ACLX
| $2.23M | 1.33% |
19,433
-6,267
| -24% | -$553K |
|
19
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $1.92M | 1.14% |
15,000
+2,000
| +15% | +$250K |
|
20
AllianceBernstein
AB
$3.57B
| $1.8M | 1.07% |
48,000
| – | – |
|
21
Arcus Biosciences
RCUS
$3.42B
| $1.75M | 1.04% |
81,241
-40,000
| -33% | -$864K |
|
22
DocGo
DCGO
$68.1M
| $1.68M | 1% |
2,670,850
| – | – |
|
|
HELP
23
Cybin Inc
HELP
$434M
| $1.68M | 1% |
350,000
+64,818
| +23% | +$419K |
|
24
Cytokinetics
CYTK
$11.2B
| $1.56M | 0.93% |
23,644
-10,356
| -30% | -$658K |
|
|
CNTA
25
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.55M | 0.92% |
39,000
+35,000
| +875% | +$895K |
|
Similar funds
DI
WA
MC
WFS
TT
7CM
MAG
PFA